Prescott General Partners LLC Humacyte, Inc. Transaction History

Prescott General Partners LLC

  • $1.5 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
SELL
$3.21 - $7.86 $182,501 - $446,872
-56,854 Reduced 9.1%
568,246 $1.82 Million
Q1 2022

May 16, 2022
BUY
$4.65 - $7.4 $2.53 Million - $4.03 Million
545,100 Added 681.38%
625,100 $4.41 Million
Q4 2021

Feb 14, 2022
BUY
$7.25 - $11.6 $580,000 - $928,000
80,000 New
80,000 $580,000

Others Institutions Holding HUMA

# of Institutions
150
Shares Held
35.1M
Call Options Held
279K
Put Options Held
607K
View Full List

About Humacyte, Inc.

HUMA Quotes by TradingView
  • Ticker HUMA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 103,007,000
  • Market Cap $478M
  • Description
  • Humacyte, Inc. engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions across a range of anatomic locations in multiple therapeutic areas. The company using its proprietary and scientific technology platform to engineer and manufacture human acellular ...
More about HUMA
Track This Portfolio

Track Prescott General Partners LLC Portfolio

Follow Prescott General Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prescott General Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Prescott General Partners LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email